Related Experiment Video
Updated: May 6, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Release of prostaglandins from human polymorphonuclear leukocytes
1Division of Rheumatic Diseases, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut.
Abstract:
Human PMNs release prostaglandins E and F to the surrounding medium when these cells are exposed to zymosan. PGE1 is the prostaglandin compound found in highest concentration in the medium, and the PGE/PGF balance is approximately 3∶1. Release of prostaglandins is not due to platelet contamination. Agents which inhibit prostaglandin synthesis (indomethacin, aspirin) prevent release of prostaglandins from phagocytic cells. Addition to cells of dibutyryl cyclic 3',5'-adenosine monophosphate produces striking increases in concentrations of prostaglandins released during ingestion of zymosan. Prostaglandins appear to be synthesized by human PMN during phagocytosis, and their release from cells may help regulate the inflammatory response.
Insights
Human neutrophils (PMNs) release prostaglandins during zymosan-induced phagocytosis. Prostaglandin E1 is most abundant, and their release is inhibited by indomethacin and aspirin, suggesting synthesis by PMNs to regulate inflammation.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Human polymorphonuclear neutrophils (PMNs) are key immune cells involved in inflammatory responses.
- Prostaglandins are lipid compounds with diverse physiological roles, including inflammation modulation.
Purpose of the Study:
- To investigate the release and synthesis of prostaglandins by human PMNs during phagocytosis.
- To determine the types and relative concentrations of prostaglandins released.
- To explore the role of cyclic AMP in prostaglandin release.
Main Methods:
- Exposure of human PMNs to zymosan particles to stimulate phagocytosis.
- Measurement of prostaglandin E (PGE) and F (PGF) in the surrounding medium using radioimmunoassay.
- Inhibition studies using indomethacin and aspirin to assess prostaglandin synthesis.
- Addition of dibutyryl cyclic 3',5'-adenosine monophosphate (dBcAMP) to evaluate its effect on prostaglandin release.
Main Results:
- Human PMNs released both PGE and PGF into the medium after zymosan exposure.
- PGE1 was the predominant prostaglandin, with a PGE/PGF ratio of approximately 3:1.
- Prostaglandin release was inhibited by indomethacin and aspirin, indicating de novo synthesis by PMNs.
- Addition of dBcAMP significantly increased prostaglandin release during zymosan ingestion.
Conclusions:
- Human PMNs synthesize prostaglandins during phagocytosis.
- The release of prostaglandins by PMNs may play a role in regulating the inflammatory response.
- Cyclic AMP signaling may influence prostaglandin production and release in phagocytic cells.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
11:03High Throughput Measurement of Extracellular DNA Release and Quantitative NET Formation in Human Neutrophils In Vitro
Published on: June 18, 2016
Related Concept Videos
Acute Inflammation I: Cellular Phase
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Local and Systemic Effects
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Differentiation of Common Myeloid Progenitor Cells